Julia Kenny
Scientific Director, Genetic toxicology & Photosafety
GlaxoSmithKline
Research Interests
Genetic Toxicology, Mutation, Cytogenetics, Toxicology, Drug Development
Finding alternative in vitro methods to predict in vivo organ toxicity and/or potential genotoxicity in pharmaceutical development.